Kisha Sivanathan (@SivanathanKisha) header
Kisha Sivanathan (@SivanathanKisha) profile picture

Senior Scientist | Bioscience, Early Discovery, Respiratory & Immunology @AstraZeneca Alumnus l @harvardmed @brighamwomens @broadinstitute @nhmrc @uniofadelaide

Boston, MA
Joined July 2015
Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)Photo by Kisha Sivanathan (@SivanathanKisha)
Just published online in Cell! My Postdoc work from the @NowarskiLab in collaboration with the Jeffrey Moffitt and Paolo Cadinu from the @MoffittLab
Thrilled to have our work mapping tissue remodeling in intestinal inflammation online! An amazing collaboration between @SivanathanKisha and Paolo and Jeff in the @MoffittLab probing the diversity and origin of #inflammation associated #fibroblasts. doi.org/10.1016/j.cell.2024.…
4
8
34
5,813
Presented + joined a panel at the #NextGenOmics Spatial & Data @OGConferences last week. Key insights: 🔬 Multi-omics expanding 🗺️ Mapping to translation 🤖 Integration with AI 🚀 Predictive & programmable biology The field is moving fast! #SpatialBiology #AI #DrugDiscovery
1
59
Multi-omics reveals immune response and metabolic profiles during high-altitude mountaineering: Cell Reports cell.com/cell-reports/fullte…
63
Kisha Sivanathan retweeted
Imagine seeing a disease's impact on every cell in the body. Now, you can! We introduce MouseMapper, an AI tool to reveal system-wide disease perturbations. MouseMapper showed obesity-induced changes in facial nerves & body-wide inflammation 👉🏼🧵biorxiv.org/content/10.1101/…
16
218
58
624
119,916
My 1000th citation milestone! 🎉🎈 So happy to have contributed to many research areas, including Kidney disease, Cell Therapies, Diabetes, Transplantation, IBD, Clinical Trial Commentaries, Infectious Disease, and Alzheirmer’s! scholar.google.com/citations…
2
112
The scientific director: A complementary model for academic leadership. sciencedirect.com/science/ar…
1
85
Bacterial-MERFISH!
So excited to announce our new method for multiplexed RNA imaging in bacterial cells: bacterial-MERFISH! A huge congratulations to the team of @AriSarfatis, Yuanyou Wang, and Nana Twumasi-Ankrah! Check out the following thread or our bioRxiv (biorxiv.org/content/10.1101/…) 1/12
4
218
Join us at the @ttsorg @CTRMS_Websocial Webinar Series where I'll be presenting my recently published postdoc research on the Cellular and Spatial Remodeling of the Colon in Colitis.
🚨Don't miss the next CTRMS webinar 👉 Young Investigator Committee Keynote Webinar Series. With Peggy Stock, Fanny Lebreton, Kisha Nandini Sivanathan & Giuseppe Pettinato. Learn more ➡️ tinyurl.com/4ec5xf79 🗓️ Weds., June 26 at 4:00 pm (ET) #TransplantTwitter #MedTwitter #TTS2024
4
212
Kisha Sivanathan retweeted
🚨Don't miss the next CTRMS webinar 👉 Young Investigator Committee Keynote Webinar Series. With Peggy Stock, Fanny Lebreton, Kisha Nandini Sivanathan & Giuseppe Pettinato. Learn more ➡️ tinyurl.com/4ec5xf79 🗓️ Weds., June 26 at 4:00 pm (ET) #TransplantTwitter #MedTwitter #TTS2024
1
1
1
571
Latest paper from our lab! @NowarskiLab
Very excited to share our paper showing that IL-18 activation of the salt transporter NCC programs durable immune tolerance in the gut! We found that NCC induces a metabolic switch in macrophages that stabilizes fatty acid oxidation and prevents glycolytic reprogramming ⬇️
4
202
Vitamin D regulates microbiome-dependent cancer immunity | Science science.org/doi/10.1126/scie…
2
135
Kisha Sivanathan retweeted
Our work shows the number of mutation-bearing lesions in the human pancreas is ~1000. The lifetime probability to develop pancreatic cancer: 1/60. So, the probability for a single lesion to become cancer is minuscule: about 1/600,000. (all approximate) nature.com/articles/s41586-0…
8
64
5
286
74,492